These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16358744)

  • 1. [Protease and reverse transcriptase genetic polymorphism in HIV type 1 subtype A variants predominating in cis countries].
    Sukhanova AL; Bogoslovskaia EV; Kruglova AI; Bashkirova LIu; Tsyganova GM; Shipulin GA; Kazennova EV; Alikina IuI; Zverev SIa; Grishechkin AE; Pokrovskiĭ VV; Bobkova MR; Bobkov AF
    Mol Biol (Mosk); 2005; 39(6):1063-71. PubMed ID: 16358744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
    Kantor R; Katzenstein D
    AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.
    Kearney M; Palmer S; Maldarelli F; Shao W; Polis MA; Mican J; Rock-Kress D; Margolick JB; Coffin JM; Mellors JW
    AIDS; 2008 Feb; 22(4):497-501. PubMed ID: 18301062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
    Balakrishnan P; Kumarasamy N; Kantor R; Solomon S; Vidya S; Mayer KH; Newstein M; Thyagarajan SP; Katzenstein D; Ramratnam B
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):301-5. PubMed ID: 15943572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.
    Roudinskii NI; Sukhanova AL; Kazennova EV; Weber JN; Pokrovsky VV; Mikhailovich VM; Bobkov AF
    J Virol; 2004 Oct; 78(20):11276-87. PubMed ID: 15452247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response.
    Ojesina AI; Sankalé JL; Odaibo G; Langevin S; Meloni ST; Sarr AD; Olaleye D; Kanki PJ
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):770-9. PubMed ID: 16910833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference.
    Han X; Zhang M; Dai D; Wang Y; Zhang Z; Liu J; Geng W; Jiang Y; Takebe Y; Shang H
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):357-64. PubMed ID: 17411368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
    Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
    J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
    Kantor R; Zijenah LS; Shafer RW; Mutetwa S; Johnston E; Lloyd R; von Lieven A; Israelski D; Katzenstein DA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1407-13. PubMed ID: 12512512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77I in protease and/or A62V in reverse transcriptase].
    Selimova LM; Serebrovskaia LV; Ivanova LA; Nosik DN
    Vopr Virusol; 2010; 55(2):22-6. PubMed ID: 20455467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Pol Gene Polymorphism and Antiretroviral Resistance Mutations in Treatment-Naive Adult Patients in French Guiana Between 2006 and 2012.
    Darcissac E; Nacher M; Adriouch L; Berlioz-Arthaud A; Boukhari R; Couppié P; Djossou F; Donato D; El Guedj M; Lavergne A; Papot E; Pouliquen JF; Tanguy E; Vantilcke V; Lacoste V
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):801-11. PubMed ID: 27009561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China.
    Liao L; Xing H; Li X; Ruan Y; Zhang Y; Qin G; Shao Y
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1062-5. PubMed ID: 17725425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
    Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
    Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: a 2005 study.
    Marechal V; Jauvin V; Selekon B; Leal J; Pelembi P; Fikouma V; Gabrie P; Heredeibona LS; Goumba C; Serdouma E; Ayouba A; Fleury H
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):1036-44. PubMed ID: 17067275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.